{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:36:10Z","timestamp":1794083770952,"version":"4.8.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Opioid use is a cause of concern in many parts of the world. About 2.1% Indians use opioids. Opioids are also the most common drugs used by injection drug users in India. Despite various treatment strategies used to manage opioid use disorders (OUDs), relapse is common. A good treatment program would make efforts to address lapses and prevent relapse. Hence, there is a need to understand the factors associated with relapse in OUD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>One hundred and twenty patients completed a baseline assessment that included socio-demographic details and the Maudsley Addiction Profile (MAP). They were followed up for three months and assessed using telephonic interview for opioid use. All those who relapsed were assessed using the Reasons for Relapse Questionnaire (RRQ). The patients who relapsed were compared with the patients who were abstinent. Relapse was defined as any use of opioid during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Forty participants relapsed during the 90 days of the study period. Relapsed patients had a greater number of conflict days with family members, used a higher amount of heroin and cannabis at baseline, were less likely to be discharged on buprenorphine, and were more likely to drop out. Participants cited mood and social reasons more often than cue\/craving and unwell domains of RRQ.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Baseline treatment and prospective factors are associated with relapse in OUD. Addressing these factors can help in reducing relapse in OUD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ipj.ipj_87_22","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T19:00:41Z","timestamp":1696618841000},"page":"361-368","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Relapse during opioid use disorder treatment: A pilot study to understand the reasons for opioid use during treatment"],"prefix":"10.4103","volume":"32","author":[{"given":"Virendra V.","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Army College of Medical Sciences and Base Hospital, Delhi Cantt, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Dhawan","sequence":"additional","affiliation":[{"name":"National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Sarkar","sequence":"additional","affiliation":[{"name":"National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani K.","family":"Mishra","sequence":"additional","affiliation":[{"name":"National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Chadda","sequence":"additional","affiliation":[{"name":"National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"R2-20240829","first-page":"176","article-title":"Lapse and relapse following inpatient treatment of opiate dependence","volume":"103","author":"Smyth","year":"2010","journal-title":"Ir Med J"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/7620860","article-title":"Predictors of relapse after inpatient opioid detoxification during 1-year follow-up","volume":"2016","author":"Chalana","year":"2016","journal-title":"J Addict"},{"key":"R4-20240829","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/0019-5545.44750","article-title":"Long-term outcome of in-patients with substance use disorders:A study from North India","volume":"50","author":"Singh","year":"2008","journal-title":"Indian J Psychiatry"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1192\/bjp.187.4.360","article-title":"In-patient treatment of opiate dependence:Medium-term follow-up outcomes","volume":"187","author":"Smyth","year":"2005","journal-title":"Br J Psychiatry"},{"key":"R6-20240829","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1192\/bjp.161.5.654","article-title":"Factors associated with relapse among opiate addicts in an out-patient detoxification programme","volume":"161","author":"Unnithan","year":"1992","journal-title":"Br J Psychiatry"},{"key":"R7-20240829","doi-asserted-by":"crossref","first-page":"1000121","DOI":"10.4172\/2155-6105.1000122","article-title":"Addiction relapse and its predictors:A prospective study","volume":"03","author":"Mohammadpoorasl","year":"2012","journal-title":"J Addict Res Ther"},{"key":"R8-20240829","first-page":"151","article-title":"Relapse prevention:An overview of Marlatt's cognitive-cehavioral model","volume":"23","author":"Larimer","year":"1999","journal-title":"Alcohol Res Health"},{"issue":"(Suppl)","key":"R9-20240829","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1111\/j.1360-0443.1996.tb02332.x","article-title":"Relapse research and the reasons for drinking questionnaire:A factor analysis of Marlatt's relapse taxonomy","volume":"91","author":"Zywiak","year":"1996","journal-title":"Addiction"},{"key":"R10-20240829","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4103\/psychiatry.IndianJPsychiatry_383_20","article-title":"Relapse in opioid dependence:Role of psychosocial factors","volume":"63","author":"Sureshkumar","year":"2021","journal-title":"Indian J Psychiatry"},{"key":"R11-20240829","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4103\/IJPSYM.IJPSYM_356_17","article-title":"A comparative study of factors associated with relapse in alcohol dependence and opioid dependence","volume":"39","author":"Kadam","year":"2017","journal-title":"Indian J Psychol Med"},{"key":"R12-20240829","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/02537176211066739","article-title":"A prospective three-months naturalistic follow-up study of outcomes of patients with opioid dependence discharged on buprenorphine or oral naltrexone","volume":"45","author":"Singh","year":"2023","journal-title":"Indian J Psychol Med"},{"key":"R13-20240829","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5055\/jom.2022.0739","article-title":"Reasons for leaving treatment among patients with opioid dependence:A 3-month prospective follow-up study","volume":"18","author":"Singh","year":"2022","journal-title":"J Opioid Manag"},{"key":"R15-20240829","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/ijsp.ijsp_65_18","article-title":"Sociodemographic profile, pattern of opioid use, and clinical profile in patients with opioid use disorders attending the de-addiction center of a tertiary care hospital in North India","volume":"35","author":"Bhat","year":"2019","journal-title":"Indian J Soc Psychiatry"},{"key":"R16-20240829","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0019-5545.174359","article-title":"Predictors of retention in treatment in a tertiary care de-addiction center","volume":"58","author":"Majumder","year":"2016","journal-title":"Indian J Psychiatry"},{"key":"R17-20240829","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/14659891.2015.1021867","article-title":"An open label naturalistic study of predictors of retention and compliance to naltrexone maintenance treatment among patients with opioid dependence","volume":"21","author":"Dayal","year":"2016","journal-title":"J Subst Use"},{"key":"R18-20240829","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome:Results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"R19-20240829","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","article-title":"Long-term retention in Office Based Opioid Treatment with buprenorphine","volume":"74","author":"Weinstein","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"R20-20240829","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsat.2015.08.009","article-title":"Factors affecting drug use during incarceration:A cross-sectional study of opioid-dependent persons from India","volume":"61","author":"Rao","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"R21-20240829","first-page":"68","article-title":"Opioid use in prison population and its relationship to crime:A review","volume":"16","author":"Goyal","year":"2011","journal-title":"J Ment Health Hum Behav"},{"key":"R22-20240829","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4103\/0253-7176.162951","article-title":"Adherence to buprenorphine maintenance treatment in opioid dependence syndrome:A case control study","volume":"37","author":"Bandawar","year":"2015","journal-title":"Indian J Psychol Med"},{"key":"R23-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.06.004","article-title":"A naturalistic study of predictors of retention in treatment among emerging adults entering first buprenorphine maintenance treatment for opioid use disorders","volume":"80","author":"Dayal","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"R25-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/SAR.S45585","article-title":"New developments in the management of opioid dependence:Focus on sublingual buprenorphine-naloxone","volume":"6","author":"Soyka","year":"2015","journal-title":"Subst Abuse Rehabil"},{"key":"R26-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7517-10-14","article-title":"Factors associated with relapse into drug use among male and female attendees of a three-month drug detoxification-rehabilitation programme in Dhaka, Bangladesh:A prospective cohort study","volume":"10","author":"Maehira","year":"2013","journal-title":"Harm Reduct J"},{"key":"R27-20240829","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.addbeh.2018.11.008","article-title":"Relapse after inpatient substance use treatment:A prospective cohort study among users of illicit substances","volume":"90","author":"Andersson","year":"2019","journal-title":"Addict Behav"},{"key":"R28-20240829","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jsat.2005.01.006","article-title":"Factors associated with 12 months continuous heroin abstinence:Findings from the Australian Treatment Outcome Study (ATOS)","volume":"28","author":"Darke","year":"2005","journal-title":"J Subst Abuse Treat"},{"key":"R29-20240829","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2014.11.016","article-title":"Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteers","volume":"146","author":"Woodcock","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"R30-20240829","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/00952998709001511","article-title":"The antecedents and benefits of achieving abstinence in opioid addicts:A 2.5-year follow-up study","volume":"13","author":"Rounsaville","year":"1987","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R31-20240829","first-page":"9","article-title":"A prospective study to investigate predictors of relapse among patients with opioid use disorder treated with methadone","volume":"10","author":"Naji","year":"2016","journal-title":"Subst Abus Res Treat"},{"key":"R32-20240829","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0376-8716(99)00063-0","article-title":"Inpatient opiate detoxification in Geneva:Follow-up at 1 and 6 months","volume":"58","author":"Broers","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"R33-20240829","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2015.04.002","article-title":"Patient perspectives associated with intended duration of buprenorphine maintenance therapy","volume":"56","author":"Bentzley","year":"2015","journal-title":"J Subst Abuse Treat"},{"key":"R34-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-8-149","article-title":"Factors predicting drop out from, and retention in, specialist drug treatment services:A case control study in the North West of England","volume":"8","author":"Beynon","year":"2008","journal-title":"BMC Public Health"},{"key":"R35-20240829","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/00952990600918973","article-title":"Behavioral therapy to augment oral naltrexone for opioid dependence:A ceiling on effectiveness\u202f?","volume":"32","author":"Nunes","year":"2006","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R36-20240829","doi-asserted-by":"crossref","first-page":"e50673","DOI":"10.1371\/journal.pone.0050673","article-title":"Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia","volume":"7","author":"Ruger","year":"2012","journal-title":"PLoS One"},{"key":"R37-20240829","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/09595239800186971","article-title":"An open trial of naltrexone for opiate dependence","volume":"17","author":"Foy","year":"1998","journal-title":"Drug Alcohol Rev"},{"key":"R38-20240829","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients:A randomized clinical trial","volume":"174","author":"Liebschutz","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R39-20240829","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1037\/0033-295X.111.1.33","article-title":"Addiction motivation reformulated:An affective processing model of negative reinforcement","volume":"111","author":"Baker","year":"2004","journal-title":"Psychol Rev"},{"key":"R40-20240829","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1037\/0003-066X.59.4.224","article-title":"Relapse prevention for alcohol and drug problems:That was Zen, this is Tao","volume":"59","author":"Witkiewitz","year":"2004","journal-title":"Am Psychol"},{"key":"R41-20240829","first-page":"e32141","article-title":"Measurement of factors influencing the relapse of addiction:A factor analysis","volume":"6","author":"Afkar","year":"2017","journal-title":"Int J High Risk Behav Addict"},{"key":"R42-20240829","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1360-0443.91.12s1.16.x","article-title":"Replication and extension of Marlatt's taxonomy of relapse precipitants:Overview of procedures and results. The Relapse Research Group","volume":"91","author":"Lowman","year":"1996","journal-title":"Addiction"},{"key":"R43-20240829","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0306-4603(91)90038-J","article-title":"Importance of substance cues in relapse among heroin users:Comparison of two methods of investigation","volume":"16","author":"Heather","year":"1991","journal-title":"Addict Behav"},{"key":"R44-20240829","first-page":"241","article-title":"A prospective study of telephonic contact and subsequent physical follow-up of radically treated lung cancer patients","volume":"56","author":"Mathew","year":"2017","journal-title":"Indian J Cancer"},{"key":"R45-20240829","doi-asserted-by":"crossref","first-page":"173","DOI":"10.26719\/2017.23.3.173","article-title":"Drop-out from a drug treatment clinic and associated reasons","volume":"23","author":"Hoseinie","year":"2017","journal-title":"East Mediterr Health J"}],"container-title":["Industrial Psychiatry Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ipj.ipj_87_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:16:49Z","timestamp":1787167009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ipj.ipj_87_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ipj.ipj_87_22","relation":{},"ISSN":["0972-6748","0976-2795"],"issn-type":[{"value":"0972-6748","type":"print"},{"value":"0976-2795","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2022-05-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}